Skip to main content
Clinical Trials/NCT05365399
NCT05365399
Terminated
Not Applicable

Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population

Picterus AS1 site in 1 country180 target enrollmentMay 3, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neonatal Jaundice
Sponsor
Picterus AS
Enrollment
180
Locations
1
Primary Endpoint
Smartphone application sensitivity (bilirubin levels on newborns)
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara.

Detailed Description

The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara. The specific objectives for this study are: To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin measurements in serum in newborns with varying degree of jaundice To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from a standard transcutaneous device in newborns with varying degree of jaundice To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from visual inspection in newborns with varying degree of jaundice

Registry
clinicaltrials.gov
Start Date
May 3, 2022
End Date
August 15, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Infants born with gestational age ≥37 weeks
  • Birth weight ≥2000g and ≤4500g
  • Age 1 - 14 days
  • Infants requiring a blood sample (newborn screening / clinically suspected jaundice)

Exclusion Criteria

  • Infants transferred to the paediatric ward for advanced treatment.
  • Infants with a skin rash or other disease that affects the skin where measurements are performed.
  • Infants that receive or have received phototherapy in the last 24 hours.
  • Infants with an inborn disease

Outcomes

Primary Outcomes

Smartphone application sensitivity (bilirubin levels on newborns)

Time Frame: 5 minutes

Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Secondary Outcomes

  • Smartphone application sensitivity (bilirubin levels on newborns with high melanin content) in the skin.(5 minutes)

Study Sites (1)

Loading locations...

Similar Trials